Randomized phase II study of docetaxel in combination with Zactima (ZD6474) [vandetanib] in patients with locally advanced squamous cell carcinoma of the head and neck
Phase of Trial: Phase II
Latest Information Update: 02 Jul 2013
At a glance
- Drugs Docetaxel; Vandetanib
- Indications Head and neck cancer
- Focus Therapeutic Use
- 01 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Nov 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 19 Apr 2007 New trial record.